S100 Proteins, Cytokines, and Chemokines as Tear Biomarkers in Children with Juvenile Idiopathic Arthritis-associated Uveitis.
Angeles-Han, ST; Miraldi Utz, V; Thornton, S; Schulert, G; Rodriguez-Smith, J; Kauffman, A; Sproles, A; Mwase, N; Hennard, T; Grom, A; et al.
Ocular Immunology and Inflammation.
2021;
1-5.
Uveitis in Children and Adolescents.
Chang, MH; Shantha, JG; Fondriest, JJ; Lo, MS; Angeles-Han, ST.
Rheumatic Disease Clinics of North America.
2021;
47:619-641.
Immediate effect of the COVID-19 pandemic on patient health, health-care use, and behaviours: results from an international survey of people with rheumatic diseases.
Kennedy, K; Moni, TT; Harrison, C; Larché, MJ; Levine, M; Sattui, SE; Semalulu, T; Foster, G; Surangiwala, S; Thabane, L; et al.
The Lancet. Rheumatology.
2021;
3:e707-e714.
Challenges in pediatric uveitis: update on systemic management of pediatric noninfectious uveitis (NIU) and family perspective.
Miraldi Utz, VA; Lerman, MA; Stahl, ED; Davidson, SL; Kassem, I; Jung, J; Levin, A; Catherine, C; Dehne, S; LaMattina, K; et al.
Journal of AAPOS.
2021;
25.
Update on biologic therapies for juvenile idiopathic arthritis-associated uveitis.
Thomas, J; Kuthyar, S; Shantha, JG; Angeles-Han, ST; Yeh, S.
2021;
6.
Prevalence of autoimmune diseases and other associated conditions in children and young adults with juvenile idiopathic arthritis.
Lovell, DJ; Huang, B; Chen, C; Angeles-Han, ST; Simon, TA; Brunner, HI.
RMD Open.
2021;
7.
Comprehensive assessment of quality of life, functioning and mental health in children with juvenile idiopathic arthritis and non-infectious uveitis.
McDonald, J; Cassedy, A; Altaye, M; Andringa, J; Cooper, AM; Drews-Botsch, C; Engelhard, G; Hennard, T; Holland, GN; Jenkins, K; et al.
Arthritis Care and Research.
2021.
Ophthalmology perspectives on the management of juvenile idiopathic arthritis-associated uveitis: Eyeing the need for global, multidisciplinary collaborations.
Angeles-Han, ST; Yeh, S.
Clinical and Experimental Ophthalmology.
2021;
49:12-14.
Discontinuing adalimumab in patients with controlled juvenile idiopathic arthritis-associated uveitis (ADJUST-Adalimumab in Juvenile Idiopathic Arthritis-associated Uveitis Stopping Trial): study protocol for a randomised controlled trial.
Acharya, NR; Ebert, CD; Kelly, NK; Porco, TC; Ramanan, AV; Arnold, BF; Doan, T; Gonzales, JA; von Scheven, E; Angeles-Han, ST; et al.
Trials.
2020;
21.
Assessing the validity and reliability of the Effects of Youngsters' Eyesight on Quality of Life (EYE-Q) questionnaire among children with uveitis.
Cassedy, A; Altaye, M; Andringa, J; Cooper, AM; Drews-Botsch, C; Engelhard, G; Hennard, T; Holland, GN; Jenkins, K; Lambert, SR; et al.
Arthritis Care and Research.
2020.